Option Chain

Dianthus Therapeutics Inc

DNTHNASDAQ · USD

90.71USD-2.73 (-2.93%)

2310

Dianthus Therapeutics Inc (DNTH) Option Chain

As of September 23, 2026, Dianthus Therapeutics Inc is trading at $90.71, a -2.93% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 64.8%. IV Rank is 53%.

Tracking the DNTH option chain helps you see every strike and expiry on Dianthus Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Dianthus Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of DNTH options activity at a glance. Use our scanner to monitor the DNTH option chain in real time and filter for the DNTH options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For DNTH stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the DNTH option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where DNTH stock options are being actively traded and where they are not.

Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases. It develops DNTH103 that is in phase 1 clinical trails in patients with generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was incorporated in 2015 and is based in New York, New York.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Dianthus Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen DNTH options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of DNTH stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

IndustryBiotechnology
SectorHealthcare
IV percentile82.94% Elevated
Market cap (M$)5,227
52 weeks high-20.73%
52 weeks low190.01%
Analyst recommendationStrong Buy
1.06
Target price$140.12
54.47% above the current stock price
Dividend—
Payout ratio—
Earnings date2026-11-05
P/E—
Future P/E—
EPS (ttm)-4.15
EPS growth next 5 years-10.19%

As of September 23, 2026

CALLs									PUTs
Prob. OTM %	Open Interest	Volume	Extrinsic Value	Intrinsic Value	Bid	Ask	Strike	Moneyness %	Bid	Ask	Intrinsic Value	Extrinsic Value	Volume	Open Interest	Prob. OTM %
18.51	0	0	3.74	10.71	12.50	16.40	80.00	-14.38	—	5.00	0.00	5.00	0	0	81.49
30.13	0	0	4.84	5.71	8.50	12.60	85.00	-9.03	—	4.00	0.00	4.00	0	3	69.87
43.37	0	0	6.44	0.71	5.00	9.30	90.00	-3.68	2.15	6.00	0.00	4.08	7	3	56.63
56.67	2	0	5.10	0.00	3.20	7.00	95.00	+1.67	4.00	8.00	4.29	1.71	0	1	43.33
68.64	177	0	3.05	0.00	0.70	5.40	100.00	+7.02	6.70	11.00	9.29	-0.44	0	3	31.36

As of September 23, 2026

Browse all Option Chain tickers

Stock Statistics

Scan the full option chain in one place